☆ 4.3 Editorial Material

Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Get Full Text
Add to Collection

Journal

ANNALS OF TRANSLATIONAL MEDICINE
Volume 8, Issue 23, Pages -

Publisher

AME PUBL CO
DOI: 10.21037/atm-20-2656

Keywords

-

Categories

Oncology Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.